Results 111 to 120 of about 98,224 (178)

Clinical Impact of Gleason Pattern 5 on Doublet Versus Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer. [PDF]

Prostate
Fujimoto S, Morita T, Yamamoto Y, Inamoto T, Tamura K, Yoshikawa Y, Maenosono R, Takeuchi A, Takahara K, Sugiyama S, Komura K, Yanagisawa T, Fukuokaya W, Kimura T, Fujita K.   +14 more
europepmc   +1 more source

Neutropenia in Patients With Castration-Resistant Prostate Cancer Treated Using Cabazitaxel and Prophylactic Administration of Pegfilgrastim. [PDF]

Adv Urol
Oshinomi K, Kikuchi S, Kurokawa M, Mugita T, Inoue T, Yamagishi M, Nakagami Y, Nagata M, Sasaki H, Fuji K, Morita M, Fukagai T.   +11 more
europepmc   +1 more source

[¹⁷⁷Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing. [PDF]

Curr Oncol
Buonerba C, Di Lorenzo G.
europepmc   +1 more source

Multidisciplinary Management of Severe Taxane-Induced Nail Toxicity in a Breast Cancer Patient. [PDF]

Cancer Manag Res
Sauer N, Kowalczuk M, Arkada A, Calik J.
europepmc   +1 more source

Ultrasound-Activated Microbubbles for Precision Chemo-Radioenhancement in Prostate Cancer: Sonoporation, Therapeutic Synergy, and Translational Pathways. [PDF]

Cancers (Basel)
Almasri F, Karshafian R.
europepmc   +1 more source

Overcoming Docetaxel Resistance in Prostate Cancer by Targeting Cell Cycle Progression with Narciclasine-Based Compounds. [PDF]

ACS Omega
Silva Machado R, S Gomes K, B Farias A, Meneses Araújo N, Barbosa Chanes G, Pinto Dias LM, Zaia Franco Ferreira B, Lopes CC, Rubio IGS, Moreira Simabuco F, G G Rando D, Pequeno Monteiro H, Garcia Erustes A, Smaili SS, Ryffel D, Sarlah D, Cerchiaro G, Lago JHG, Tamura RE.   +18 more
europepmc   +1 more source

Targeting KRAS^G12C in non-small cell lung cancer: evidence from randomized clinical trials and future therapeutic strategies. [PDF]

Front Oncol
Piekarz J, Picheta N, Pobideł J, Gierulska N, Kłodnicka K, Januszewski J, Szklener K, Skórzewska M.   +7 more
europepmc   +1 more source

Real-World PSA Response and Overall Survival Among Men with mCSPC Receiving Apalutamide Versus Darolutamide (Both Without Docetaxel) in the US. [PDF]

Adv Ther
Bilen MA, Brown G, Singhal M, Rossi C, Pilon D, Longfield CD, Lowentritt B.   +6 more
europepmc   +1 more source

Complete Response Demonstrated by [¹¹C]methionine-PET Imaging of a Patient With Squamous-cell Carcinoma of the Tongue Treated With Chemotherapy, Immunotherapy and Methionine Restriction Without Radiation or Surgery: A Potential New Low-toxicity Treatment Paradigm for a Recalcitrant Disease. [PDF]

In Vivo
Ishiguro T, Sato T, Han Q, Li S, Miyashi Y, Kang BM, Song SYT, Tsunoda T, Hoffman RM.   +8 more
europepmc   +1 more source